Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A patient with
chronic myeloid leukemia
developed hypercalcemia as a presenting sign of the accelerated phase of the disease. Ultrasound of the neck showed a large hypodense mass connected to the thyroid gland, which was thought to be a parathyroid tumor and the cause of the hypercalcemia. Histology of the surgically removed mass revealed a chloroma. The patient's course was complicated by respiratory failure and metastatic
calcinosis
of the lung, an unusual finding in hypercalcemia of short duration.
...
PMID:Accelerated phase of chronic myeloid leukemia presenting with hypercalcemia and a mediastinal mass. 964 3
Systemic sclerosis is a chronic multisystem disorder of unknown etiology characterized by the involvement of skin and visceral organs caused by an accumulation of collagen. It has been reported that the incidence of solid and hematological malignancy increased in systemic sclerosis. Multiple myeloma and chronic lymphocytic leukemia are the most common hematological malignancies seen in patients with systemic sclerosis.
Chronic myeloid leukemia
(
CML
) has only rarely been reported so far. We here report a case with CREST (
calcinosis
, Raynaud's phenomenon, esophageal dysfunction, sclerodactly, telangiectasia) who developed
CML
7 years after the onset of CREST. Ours is the second case with
CML
developing after the onset of CREST in the literature. We also briefly discuss the possible tendency to hematological malignancy in systemic sclerosis.
...
PMID:Scleroderma and chronic myeloid leukemia: a sheer coincidence, a consequence of long lasting D-penicillamine therapy or a plausible relationship of both diseases? 1687 7
Calcinosis cutis is a poorly understood process in which calcium salts deposit in the skin and subcutaneous tissues. Due to its multifactorial pathogenesis, several subtypes and potential etiologies have been described. Presented here is a case of bilateral pretibial
calcinosis
cutis in a patient on long-term tyrosine kinase inhibitor therapy for
chronic myeloid leukemia
. The patient initially presented with a right tibial ulceration treated with multiple surgical debridements, antibiotics, and negative pressure wound therapy. The wound was ultimately closed with a split-thickness skin graft. Relevant literature is examined and several possible mechanisms are discussed.
...
PMID:Calcinosis cutis presenting in the context of long-term therapy for chronic myeloid leukemia: a case report and review of the literature. 2578 4